SS Innovations International Appoints Sarah Romano as CFO to Drive Financial Strategy and FDA Pursuit

SS Innovations International (NASDAQ: SSII), a developer of surgical robotic technologies, has appointed Sarah M. Romano as chief financial officer, effective Aug. 3, 2026. Romano brings more than two decades of finance leadership experience in the medical technology and life sciences sectors. Based in the United States, she will help lead the company’s financial operations as it advances its global expansion strategy, including pursuit of U.S. FDA approval for its SSi Mantra surgical robotic system.

Most recently, Romano served as chief financial officer of Vicarious Surgical, where she led financial and operational initiatives to reduce cash burn, strengthen the balance sheet and support strategic objectives. She previously held CFO roles at Entero Therapeutics and Kiora Pharmaceuticals, raising more than $100 million through public and private financings while overseeing strategic transactions, SEC reporting and investor relations. Her experience in capital markets and financial stewardship is expected to be instrumental as SSII scales its operations.

The appointment comes at a critical time for SS Innovations, which develops innovative surgical robotic technologies with a vision to make robotic surgery affordable and accessible globally. The company’s product range includes its proprietary SSi Mantra surgical robotic system and a comprehensive suite of SSi Mudra surgical instruments, which support a variety of procedures including cardiac surgery. An American company headquartered in India, SS Innovations plans to expand the global presence of its technologically advanced, user-friendly, and cost-effective surgical robotic solutions.

Romano’s role will be pivotal in guiding the company through regulatory milestones and financial planning. The pursuit of FDA approval for the SSi Mantra system represents a significant step toward entering the U.S. market, where demand for minimally invasive surgical options continues to grow. With her track record of raising capital and optimizing financial performance, Romano is expected to help SSII navigate the complexities of public company operations and strategic growth.

For more details on the announcement, view the full press release at https://ibn.fm/pAqlP. Information about SS Innovations is available on the InvestorBrandNetwork website, along with full terms of use and disclaimers at http://IBN.fm/Disclaimer.

Forward-looking statements in this article involve risks and uncertainties. These forward-looking statements are subject to various factors beyond management's control, including those set forth under "Risk Factors" in the Company's SEC filings. Undue reliance should not be placed on these statements, and the Company undertakes no duty to update them unless required by law.